Page 53 - Read Online

Casadei et al. J Cancer Metastasis Treat 2022;8:21 https://dx.doi.org/10.20517/2394-4722.2022.05 Page 15 of 19

DECLARATIONS
Authors’ contributions
Conceptualization: Casadei B, Nanni L, Lolli G, Zinzani PL
Methodology: Casadei B, Zinzani PL
Writing - original draft preparation: Casadei B, Nanni L, Lolli G, Zinzani PL
Writing - review and editing: Casadei B, Zinzani PL
Supervision: Casadei B, Zinzani PL

Availability of data and materials
Not applicable.

Financial support and sponsorship
None.

Conflicts of interest
All authors declared that there are no conflicts of interest.

Ethical approval and consent to participate
Not applicable.

Consent for publication
Not applicable.

Copyright
© The Author(s) 2022.

REFERENCES
1. Swerdlow SH, Campo E, Pileri SA, et al. The 2016 revision of the World Health Organization classification of lymphoid neoplasms.
Blood 2016;127:2375-90. DOI PubMed PMC
2. Junlén HR, Peterson S, Kimby E, et al. Follicular lymphoma in Sweden: nationwide improved survival in the rituximab era,
particularly in elderly women: a Swedish Lymphoma Registry study. Leukemia 2015;29:668-76. DOI PubMed
3. Ardeshna KM, Qian W, Smith P, et al. Rituximab versus a watch-and-wait approach in patients with advanced-stage, asymptomatic,
non-bulky follicular lymphoma: an open-label randomised phase 3 trial. Lancet Oncol 2014;15:424-35. DOI PubMed
4. Ott G, Katzenberger T, Lohr A, et al. Cytomorphologic, immunohistochemical, and cytogenetic profiles of follicular lymphoma: 2
types of follicular lymphoma grade 3. Blood 2002;99:3806-12. DOI PubMed
5. Bosga-Bouwer AG, van Imhoff GW, Boonstra R, et al. Follicular lymphoma grade 3B includes 3 cytogenetically defined subgroups
with primary t(14;18), 3q27, or other translocations: t(14;18) and 3q27 are mutually exclusive. Blood 2003;101:1149-54. DOI
PubMed
6. Loeffler M, Kreuz M, Haake A, et al; HaematoSys-Project. Genomic and epigenomic co-evolution in follicular lymphomas.
Leukemia 2015;29:456-63. DOI PubMed
7. Sarkozy C, Huet S, Carlton VE, et al. The prognostic value of clonal heterogeneity and quantitative assessment of plasma circulating
clonal IG-VDJ sequences at diagnosis in patients with follicular lymphoma. Oncotarget 2017;8:8765-74. DOI PubMed PMC
8. Tsujimoto Y, Cossman J, Jaffe E, Croce CM. Involvement of the bcl-2 gene in human follicular lymphoma. Science 1985;228:1440-
3. DOI PubMed
9. Limpens J, Stad R, Vos C, et al. Lymphoma-associated translocation t(14;18) in blood B cells of normal individuals. Blood
1995;85:2528-36. PubMed
10. Smith KG, Light A, O’Reilly LA, Ang SM, Strasser A, Tarlinton D. bcl-2 transgene expression inhibits apoptosis in the germinal
center and reveals differences in the selection of memory B cells and bone marrow antibody-forming cells. J Exp Med 2000;191:475-
84. DOI PubMed PMC
11. Araf S, Wang J, Korfi K, et al. Genomic profiling reveals spatial intra-tumor heterogeneity in follicular lymphoma. Leukemia
2018;32:1261-5. DOI PubMed PMC
12. Mamessier E, Song JY, Eberle FC, et al. Early lesions of follicular lymphoma: a genetic perspective. Haematologica 2014;99:481-8.
DOI PubMed PMC